References
- Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease; a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968–72
- Aviram M. Modified forms of low density lipoprotein and atherogenesis. Atherosclerosis 1993; 98: 1–9
- Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785–92
- Esterbauer H, Rotheneder M, Striegl G. Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci Tech 1989; 91: 316–24
- Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low density lipoprotein. Am J Clin Nutr 1991; 53: 314s–321s
- Gey KF, Puska P, Jordan P. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53: 326–48
- Rimm EB, Stampfer MJ, Ascherio A. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450–6
- Ohrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J Int Med 1993; 234: 53–60
- Lapel D, Donell HM. Abnormal antioxidant defense in some tissues of congenitally obese mice. Biochem J 1984; 219: 41–9
- Tozzi E, Tozzi-Ciancarelli MG, DiMassimo C. Hemorheological parameters and body weight loss in obese children. Clin Hemorheol 1994; 14: 203–11
- Ohrvall M, Tengblad S, Ekstrand B. Malondialdehyde concentration in plasma is inversely correlated to the proportion of lineolic acid in serum lipoprotein lipids. Atherosclerosis 1994; 108: 103–10
- Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302–10
- El Saadani M, Esterbauer H, El Sayad M. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989; 30: 627–31
- Levy Y, Ben-Amotz A, Aviram M. Effect of dietary supplementation of different β-carotene isomers on lipoprotein oxidative modification. J Nutr Med 1995; 5: 13–22
- Hayek T, Oiknine J, Brook JG, Aviram M. Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun 1994; 201: 1567–74
- Arshad MAP, Bhadra S, Cohen RM, Subbiah MT. Plasma lipid peroxidation potential: a test to evaluate individual susceptibility to peroxidation. Clin Chem 1991; 37: 1756–8
- Frei B, Stocker R, Ames B. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Nad Acad Sci 1988; 85: 9748–52
- Halliwel B. Albumin–an important extracellular antioxidant?. Biochem Pharmocol 1988; 37: 569–71
- Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
- Polansky KS, Given BD, Hirsh LJ. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988; 81: 435–41
- Kolterman OG, Insel J, Saekow M, Olefsky JM. Mechanics of insulin in human obesity: evidence for receptor and post receptor defects. J Clin Invest 1980; 65: 1272–84
- Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405–12
- Haffner SM, Agil A, Mykkanen L. Plasma oxidizability in subjects wim normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 1995; 18: 646–53
- Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham Study. Ann Intern Med 1979; 90: 85–91
- Denke MA, Tempos CT, Grundy SM. Excess body weight: a recognized contributer to high blood cholesterol levels in white American men. Arch Int Med 1993; 153: 1093–103
- Levy Y, Ben-Amotz A, Dankner G. Enhanced lipid peroxidation of low density lipoprotein widi fish oil. J Optimal Nutr 1993; 2: 6–9
- Rock CL, Swendseid M. Plasma carotenoid levels in anorexia nervosa and in obese patients. Methods Enzymol 1993; 214: 116–23